Olufunmilayo I. Olopade (an haife tane a shekarar 1957 a Najeriya )[1] ta kasan ce taba da ilimin Hematology oncologist, Mataimakin Dean for Global Health da Walter L. Palmer bambanta Service Farfesa a Medicine da kuma Human Genetics a Jami'ar Chicago[2][3] Ta kuma yi aiki a matsayin darekta na Asibitin Jami'ar Chicago Asibitin Hadarin Ciwon Kansa.
An haifi Olufunmilayo Olopade a Najeriya a cikin shekara1957 kuma ita ce ta biyar cikin yara shida da wani mawaƙin Anglican ya haifa. Olopade ya fara nuna sha'awar zama likita tun yana karami saboda kauyukan Najeriya sun yi karanci ga likitoci da kayan aikin likitanci, wadanda dukkansu suna matukar bukatar hakan.[4]
Ta kammala karatun ta ne a Jami’ar Ibadan, Nijeriya, da MBBS, a 1980.[5]
Tana aiki kafada da kafada da Cibiyar Nazarin Ciwon Kanji [6] kuma ta yi aikin asibiti mai yawa game da tasirin kwayar halittar BRCA1 da BRCA2 a cikin cutar sankarar mama a cikin matan asalin Afirka.[7]
Ita memba ce a Cibiyar Nazarin Ciwon Kankara ta Amurka,[8] Kwalejin Likitocin Amurka, da Kungiyar Likitocin Najeriya, da Cibiyar Magunguna .[9][10][11]
A ranar Asabar, 18 ga Mayu, 2019, Kwalejin Lincoln ta Illinois ta ba Olopade Dokar Lincoln lambar yabo, mafi girma girmamawa da Jihar Illinois ta bayar .[17]
Olufunmilayo Olopade na ɗaya daga cikin Ba’amurke-Ba’amurke su uku da suka karɓi kyautar $ 500,000. John D. da Catherine T. MacArthur Foundation ne suka nada wannan kyautar. Wannan "babu wani abin da aka haɗa" an ba da tallafin ne a matsayin tallafi har zuwa shekaru biyar kuma an kira shi "kyautar baiwa." Wannan kyautar ta ba Olopade damar ci gaba da bincike game da abubuwan da ta gano kan cututtuka da matsalolin kiwon lafiya.
Ta auri Christopher Sola Olopade, shi ma likita ne a Jami’ar Chicago, a 1983; suna da ‘ya’ya mata biyu, ciki har da dan jarida Dayo Olopade, da kuma ɗa daya.[18]
Mafi yawan binciken nata ya kasance kan saukin kamuwa da cutar kansa, wanda daga nan ne za a yi amfani da shi don amfani da ingantacciyar hanyar kula da cutar sankarar mama a tsakanin daidaikun Afirka da Afirka-Amurkawa da yawan jama'a.
A shekarar 1987 a Jami'ar Chicago, ta sami kwayar halitta wacce ta taimaka wajen dakile ci gaban tumo.
A cikin 1992, Olopade ya taimaka ya kafa Cibiyar Nazarin Cibiyar Nazarin Ciwon cerwayar Ciwon Kanikanci ta Jami'ar Chicago. Anan ta gano cewa matan Ba-Amurkan sukan kamu da cutar sankarar mama a lokacin da suke kanana mata.[19]
A shekarar 2003, ta fara wani sabon nazari wanda ke duba kansar nono da halittar jini daga matan Afirka daga Najeriya zuwa Senegal da ma matan Ba-Amurke a Chicago. A shekara ta 2005 ta gano cewa kashi 80% na ciwan ciki a cikin matan Afirka ba sa buƙatar estrogen don ya girma idan aka kwatanta da kashi 20% na ƙari a cikin matan Caucasian. Ta kuma gano cewa wannan ya samo asali ne daga wani salo na nuna jinsi tsakanin matan Afirka da matan Caucasian.[20]
↑"Olufunmilayo I. Olopade". AACR. American Association for Cancer Research. 2001. Archived from the original on September 29, 2013. Retrieved June 6, 2013.
↑Ikpatt, Offiong Francis; Olopade, Olufunmilayo I. (2006), Williams, Christopher Kwesi O.; Olopade, Olufunmilayo I.; Falkson, Carla I. (eds.), "Genetics of Breast Cancer in Women of African Descent: An Overview", Breast Cancer in Women of African Descent (in Turanci), Dordrecht: Springer Netherlands, pp. 23–37, doi:10.1007/978-1-4020-3664-4_2, ISBN978-1-4020-3664-4